Meeting News CoverageVideo

VIDEO: 6-mercaptopurine intake often over-reported during pediatric ALL maintenance therapy

ORLANDO, Fla. — Ryan D. Cassaday, MD, reacts to results of a study presented at the ASH Annual Meeting and Exposition that showed over-reporting of 6-mercaptopurine intake appeared common during maintenance therapy among children with acute lymphoblastic leukemia.

ORLANDO, Fla. — Ryan D. Cassaday, MD, reacts to results of a study presented at the ASH Annual Meeting and Exposition that showed over-reporting of 6-mercaptopurine intake appeared common during maintenance therapy among children with acute lymphoblastic leukemia.

    See more from ASH Annual Meeting and Exposition